
ALT An illustrated diagram from the editorial "Science behind the Study: Optogenetics in Sight" that shows direct and indirect translational optogenetics pathways. Panel A: Precise identification of causal cells and circuits allows principled targeting, whether through direct (left), indirect neuromodulatory (middle), or indirect medicinal (right) approaches. Panel B: Components of direct optogenetics for retinitis pigmentosa are shown, including the adeno-associated virus (AAV) (top), the light-projecting goggles (middle), and the channelrhodopsin protein (bottom). The NEJM identity sits at the bottom.

ALT Graph from a study published in the New England Journal of Medicine on daraxonrasib versus chemotherapy for metastatic pancreatic cancer. The x-axis represents months, and the y-axis shows the percentage of patients alive. Two lines indicate survival rates: daraxonrasib (blue) and chemotherapy (gray). The bottom section lists patients at risk over time. Title and journal logo are included.
























